Julie Segal is an Editor at Institutional Investor. She covers a range of topics including finance, asset management, and investing, with a particular focus on hedge funds, investment strategies, and alternative investments. Her work has been featured in Institutional Investor, RealClearMarkets, and The Hill Times.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Julie's coverage primarily focuses on investment analysis and data citations within the finance and economy sector, with an emphasis on topics related to asset management, private equity, and investing. She may be interested in receiving pitches from experts who can provide unique insights into the current trends and future outlook of these areas.
Given her focus on citing data, sources providing statistically backed information or industry-specific reports could be particularly valuable for Julie's articles. Additionally, individuals with a strong understanding of financial regulations or those closely following market shifts may find success when reaching out to her.
While there is no specific geographic focus mentioned for Julie's coverage, it is evident that she takes a broad view of global economic trends. Therefore, international perspectives or examples would likely resonate well in pitches directed towards her.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Institutional investors have long used exchange-traded funds as a stopgap — equitizing cash or maintaining market exposure while shifting assets between managers.
By: Julie Segal
But some of those credit investments now come with a different set of assumptions: that growth will continue, that these companies won't be disrupted by changes like AI, that capital markets will stay open, and that managers can easily get out of their investments. That sounds like a stock. And in many cases, it behaves like one too.
By: Michael Thrasher, Julie Segal
Contact Info
By: Julie Segal
The problem with “semi-liquid” funds might start with the name. When I spoke to Luke Sarsfield of alternative investment firm Ridgepost Capital, he made a simple point: people hear “semi-liquid”… and miss the “semi.” They just hear “liquid.”
Biotech doesn’t typically fail in the lab. It fails later — after early promise and before approval — when the cost of proving a drug works comes up against a funding system built for an earlier stage.
The sharp reversal in global equity markets in April posed a familiar challenge for quantitative hedge funds as markets did a flip from crisis mode to a more optimistic view faster than most models are designed to adapt.The PivotalPath Equity Quant Index rose 0.9 percent last month. While that performance was a tiny fraction of the gains for directional equity strategies, the fact that quants finishing the month in positive territory was a good signal of the funds' resilience.
By: Julie Segal
When Jonathan Grabel, the CIO of Los Angeles County Employees Retirement Association since 2017, was bringing the management of co-investments in-house, he had part of his team travel to meet with private equity firms, institutional investors, and investment banks to learn about their approaches to internal investment committees, including voting on decisions.
By: Julie Segal
As asset managers consolidated, Liolis believed Guardian faced a choice. It could continue trying to build a traditional in-house investment organization, competing for talent and directly originated deals against much larger firms. Or it could rethink the model, particularly as scale in asset management began to move beyond what a firm this size could realistically replicate.
The sharp reversal in global equity markets in April posed a familiar challenge for quantitative hedge funds as markets did a flip from crisis mode to a more optimistic view faster than most models are designed to adapt.The PivotalPath Equity Quant Index rose 0.9 percent last month. While that performance was a tiny fraction of the gains for directional equity strategies, the fact that quants finished the month in positive territory was a good signal of the funds' resilience.
Hedge funds have had a quite a streak in delivering on their promises to investors in recent years, but they’re not invincible.Few strategies have emerged unscathed after the Iran war and the skyrocketing price of oil sent markets reeling last month. Both the Nasdaq and the Dow Industrials fell into correction territory and all sectors of the S&P 500 fell, except energy. Treasurys also dropped right along with stocks. Traders with bets that interest rates would fall were stymied by the prospect of higher inflation from snarled supply chains and soaring gas prices.
